Maiva Pharma raises Rs 1000 crore from Morgan Stanley Private Equity, InvAscent

Morgan Stanley PE Asia and India Life Sciences Fund are investing almost equally, total stake with both funds combined will be over 60% post primary investment, the company told ET.